A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function

FEBS Letters
J M QuillanJ K Chang

Abstract

Chemical synthesis of Agouti proteins - Agouti and Agouti-related proteins - is complicated by their large size and by multiple cysteine residues located in the carboxyl terminal regions. Three human Agouti-related protein (AGRP) fragments, two of which correspond to a proposed endoprotease cleavage site between amino acids 82 and 83, were synthesized and tested for anti-melanotropic activity using Xenopus laevis dermal melanophores. Amino-terminal fragments AGRP(25-51) and (54-82) were devoid of significant antagonist activity, whereas the amidated carboxyl-terminal AGRP fragment (83-132)-NH2 was potently active with an inhibitory equilibrium dissociation constant (Ki) of 0.7 nM. The ability to synthesize functionally active AGRP should help unravel its role in the central nervous system and its unusual properties with respect to interaction with the melanocortin family of G-protein coupled receptors.

References

Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·J M QuillanM R Lerner
Feb 1, 1995·Human Molecular Genetics·B D WilsonG S Barsh
Jun 1, 1997·The Journal of Investigative Dermatology·I SuzukiZ A Abdel-Malek
Jun 1, 1997·Pharmaceutical Research·J M Quillan, W Sadée
Dec 6, 1997·Nature·R J SeeleyM W Schwartz

❮ Previous
Next ❯

Citations

May 13, 2008·Cellular and Molecular Life Sciences : CMLS·O Ilnytska, G Argyropoulos
May 10, 2011·Cellular and Molecular Life Sciences : CMLS·Bart C De JongheKendra K Bence
Dec 31, 2003·Neuropeptides·Todd E ThieleInmaculada Cubero
Jun 18, 2005·Peptides·Adrian M StützGeorge Argyropoulos
Dec 14, 2002·Pharmacology, Biochemistry, and Behavior·William R CrowleyBrianne Hurst
Apr 14, 2007·Annual Review of Nutrition·Kathryn Moynihan RamseyJoseph Bass
Sep 14, 2001·Biochemical and Biophysical Research Communications·D K MayfieldG Argyropoulos
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·R J MiltenbergerE J Michaud
Jun 25, 2005·Alcoholism, Clinical and Experimental Research·Montserrat NavarroTodd E Thiele
Dec 3, 2003·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Y K Yang, C M Harmon
Aug 25, 2015·Frontiers in Systems Neuroscience·Allison K GraebnerMatthew E Carter
Mar 5, 2016·Journal of Molecular Endocrinology·Erica J P AndersonMichael J Litt
Sep 20, 2006·Neuron·Alfonso AbizaidTamas L Horvath
Dec 23, 2006·Chemistry & Biology·Pilgrim J JacksonGlenn L Millhauser
Dec 7, 2007·FEBS Letters·Qian Gao, Tamas L Horvath
Oct 27, 2009·Endocrine Reviews·Oren Froy
Jul 9, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Masamitsu IwasaHreday N Sapru
Jan 6, 2001·Molecular Endocrinology·W A NijenhuisR A Adan
Jul 18, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M M HaganR J Seeley
Feb 15, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M M HaganR J Seeley
Nov 11, 2005·The American Journal of Clinical Nutrition·Ruth J F LoosGeorge Argyropoulos
Dec 22, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·Y YoungM Haniu
Nov 16, 2001·Journal of Medicinal Chemistry·R ThirumoorthyC Haskell-Luevano
Jun 6, 2003·Biochemical and Biophysical Research Communications·Mohamed RachedArmelle Penhoat
Jul 28, 2005·Peptides·Boman G Irani, Carrie Haskell-Luevano
Jul 6, 2005·Peptides·Lynn E Pritchard, Anne White

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.